Puma Biotechnology, Inc. (PBYI)


NYSE - NYSE Real Time Price. Currency in USD
66.06-1.20 (-1.78%)
At close: 4:01 PM EDT
People also watch:
CLVSICPTKITEMDVNAGIO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open67.08
Prev Close67.26
Bid30.21 x 100
Ask65.99 x 300
Day's Range65.89 - 68.80
52wk Range19.74 - 94.93
1y Target EstN/A
Market Cap2.15B
P/E Ratio (ttm)-8.25
Beta-0.01
Volume964,926
Avg Vol (3m)843,171
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com33 minutes ago

    Biotech Stock Mailbag: Dynavax, Puma, Ariad

    TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

  • Reuters14 hours ago

    SEC charges former Puma Biotech employee with insider trading

    A former executive for biopharmaceutical company Puma Biotechnology Inc was charged on Thursday by the top U.S. securities regulator and prosecutors with trading on inside information ahead of a company announcement about its breast cancer drug. Robert Gadimian, former regulatory affairs director for Los Angeles-based Puma, pocketed more than $1.1 million by secretly trading on Puma stock based on non-public information he learned about positive developments in two clinical trials for the company's drug, Neratinib, the SEC said in a statement. A U.S. grand jury in Boston on Thursday also indicted Gadimian on felony charges of insider trading, according to court documents.

  • Forbes3 days ago

    Momentum Carries Lululemon Lower, Pushes Biotech Names Higher

    Two biotechs and a technology company are among the three momentum charts to watch today, with the lone short being a retailer. Array BioPharma (ARRY) had an explosive move on Monday, up $2.96, or 81%, to $6.61, on 101 million shares. The company said its melanoma treatments met its primary goal